This project was one of a number of a joint venture projects between IDC and Shaily Engineering to develop a platform of generic drug delivery pens for use by different pharma brands. This project specifically was to develop a single dose, three dose and 60 unit insulin pen variants for delivery of drugs such as Abaloparatide, Liragludtide or insulin Glargine.
Injection pen's are notorious for being highly complex and patent protected, so this project required careful navigating around existing patents, whilst utilising mechanisms from those that were expiring, to develop a unique device.
The outcome was a novel device that met all of the tight controls and requirements for FDA approval, and also featured a unique 'last dose lockout' mechanism and patented assembly method.
The device features bio-compatible materials and components that have been engineered and tightly controlled to optimise function and usability. The industrial design and aesthetics were well considered for any brand to easily utilise the platform as part of their product range.
I lead the design of this project at all stages including Mechanical Concepts & Industrial Design, through to Design for Manufacture & Engineering Drawings.
Patent Analysis
Mechanical Concept Design
Industrial Design
Design for Manufacture
CAD Modelling
Engineering
Manufacture Liaison
Designed at IDC